ABVC BioPharma
ABVC
ABVC
5 hedge funds and large institutions have $498K invested in ABVC BioPharma in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$41K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$6K |
| 3 |
AC
3
Armistice Capital
New York
|
$1.16K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $398K | 375,142 | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $52K | 49,915 | – | – |
|
|
3
BlackRock
New York
| $41K | 39,042 | +39,042 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $6K | 5,997 | +5,997 | New |
|
|
AC
5
Armistice Capital
New York
| $1.16K | 1,092,745 | +1,092,745 | New |
|
|
6
Morgan Stanley
New York
| – | – | -1,460 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | – | -1,274 | Closed |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|